Sumitomo Mitsui DS Asset Management Company Ltd Grows Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in HCA Healthcare by 3.8%, now owning 25,421 shares valued at approximately $9.74 million.
• HCA Healthcare's recent quarterly earnings topped estimates with $6.84 earnings per share, surpassing the expected $6.20, and revenues grew by 6.4% year-over-year.
• A quarterly dividend of $0.72 was announced, with an annualized yield of 0.7%, reflecting the company's steady income return strategy for investors.

Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,421 shares of the company's stock after buying an additional 925 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in HCA Healthcare were worth $9,739,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD grew its stake in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of HCA Healthcare by 40,527.3% in the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares in the last quarter. Nuveen LLC bought a new position in shares of HCA Healthcare in the first quarter worth $569,217,000. Finally, Pacer Advisors Inc. grew its stake in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by company insiders.

HCA Healthcare Trading Up 0.4%

Shares of NYSE HCA opened at $400.95 on Friday. The business has a fifty day simple moving average of $384.69 and a 200-day simple moving average of $365.16. The company has a market cap of $93.82 billion, a price-to-earnings ratio of 16.85, a P/E/G ratio of 1.26 and a beta of 1.41. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a report on Wednesday, September 10th. JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, Barclays raised their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an "overweight" rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $407.75.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.